Wfa Asset Management Corp Organon & Co. Transaction History

Wfa Asset Management Corp

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Oct 13, 2023	SELL	$19.27 - $24.63 $1,425 - $1,822	-74 Closed	0 $0
Q1 2023 Oct 13, 2023	BUY	$21.42 - $32.08 $21 - $32	1 Added 1.37%	74 $1.74 Million
Q4 2022 Oct 13, 2023	BUY	$23.31 - $28.61 $23 - $28	1 Added 1.39%	73 $2.03 Million
Q3 2022 Oct 13, 2023	BUY	$23.4 - $34.25 $23 - $34	1 Added 1.41%	72 $1.69 Million
Q1 2022 Oct 13, 2023	SELL	$30.45 - $39.36 $1,248 - $1,613	-41 Reduced 36.61%	71 $2.47 Million
Q4 2021 Oct 13, 2023	BUY	$28.67 - $37.13 $3,211 - $4,158	112 New	112 $3.41 Million

790

193M

1.71M

865K

Ticker OGN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 254,330,000
Market Cap $3.82B
Description
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...

Get notified when there are updates to the investment portfolio of Wfa Asset Management Corp, based on Form 13F filings with the SEC.

Stay updated on Wfa Asset Management Corp with notifications on news.